Induction of apoptosis in HeLa cells by 3β-hydroxyurs-12-en-27-oic acid

Chemistry and Biodiversity

Volumn 3, Issue 7, 2006, Pages 742-753

  Zheng, Quan Fang ^a,b   Sun, Hong Xiang ^a   He, Qiao Jun ^c   Ye, Yi Peng ^d  

^a ZHEJIANG UNIVERSITY   (China)

^b Xinyang Agriculture and Forestry University   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXYURS 12 EN 27 OIC ACID; ASPARTIC ACID; ASTILBE CHINENSIS EXTRACT; CASPASE 3; CASPASE 3 INHIBITOR; DNA; FUNCTIONAL GROUP; GLUTAMINE; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; TRITERPENOID; UNCLASSIFIED DRUG; URSOLIC ACID; VALINE;

AGAR GEL ELECTROPHORESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTILBE CHINENSIS; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVITY; FLOW CYTOMETRY; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; MITOCHONDRIAL MEMBRANE; PROTEIN EXPRESSION; RHIZOME; SAXIFRAGACEAE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 3; CELL SHAPE; CRICETINAE; DNA FRAGMENTATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; MEMBRANE POTENTIALS; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIAL MEMBRANES; MOLECULAR STRUCTURE; PROTO-ONCOGENE PROTEINS C-BCL-2; TRITERPENES;

ASTILBE CHINENSIS;

EID: 33746909456     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200690076     Document Type: Article

References (34)

1. J. D. Connolly, R. A. Hill, Nat. Prod. Rep. 2005, 22, 487.
2. L. C. Chiang, W. Chiang, M. Y. Chang, L. T. Ng, C. C. Lin, Am. J. Chin. Med. 2003, 31, 37.
3. Z. Ovesna, A. Vachalkova, K. Horvathova, D. Tothova, Neoplasma 2004, 51, 327.
4. T. Rabi, C. Ramachandran, H. B. Fonseca, R. P. Nair, A. Alamo, S. J. Melnick, E. Escalon, Breast Cancer Res. Treat. 2003, 80, 321.
5. B. C. Park, K. O. Bosire, E. S. Lee, Y. S. Lee, J. A. Kim, Cancer Lett. 2005, 218, 81.
6. H. X. Sun, Q. F. Zheng, J. Tu, Bioorg. Med. Chem. 2006, 14, 1189.
7. J. Tu, H. X. Sun, Y. P. Ye, Chem. Biodiv. 2006, 3, 69.
8. M. J. Jung, Y. C. Yoo, K. B. Lee, J. B. Kim, K. S. Song, Arch. Pharm. Res. 2004, 27, 840.
9. H. Y. Hsu, J. J. Yang, C. C. Lin, Cancer Lett. 1997, 111, 7.
10. J. Fernandes, R. O. Castilho, M. R. da Costa, K. Wagner-Souza, M. A. Coelho Kaplan, C. R. Gattass, Cancer Lett. 2003, 190, 165.
11. S. Shishodia, S. Majumdar, S. Banerjee, B. B. Aggarwal, Cancer Res. 2003, 63, 4375.
12. Y. L. Hsu, P. L. Kuo, C. C. Lin, Life Sci. 2004, 75, 2303.
13. H. X. Sun, J. X. Zhang, Y. P. Ye, Y. J. Pan, Y. M. Shen, Helv. Chim. Acta 2004, 86, 2414.
14. H. X. Sun, Y. P. Ye, Y. J. Pan, J. Ethnopharmacol. 2004, 90, 261.
15. M. T. Hang, C. T. Ho, Z. Y. Wang, T. Ferraro, Y. R. Lou, K. Stauber, W. Ma, C. Georgiadis, L. D. Laskin, A. H. Conney, Cancer Res. 1994, 54, 701.
16. T. Konoshima, M. Takasaki, H. Tokuda, K. Masuda, Y. Arai, K. Shiojima, H. Ageta, Biol. Pharm. Bull. 1996, 19, 962.
17. H. J. Cha, S. K. Bae, H. Y. Lee, O. H. Lee, H. Sato, M. Seiki, B. C. Park, K. W. Kim, Cancer Res. 1996, 56, 2281.
18. J. H. Baek, Y. S. Lee, C. M. Kang, J. A. Kim, K. S. Kwon, H. C. Son, K. W. Kim, Int. J. Cancer 1997, 73, 725.
19. F. Sun, S. Akazawa, K. Sugahara, S. Kamihira, E. Kawasaki, K. Eguchi, T. Koji, Arch. Histol. Cytol. 2002, 65, 145.
20. P. W. Hyun, C. Y. Hee, J. C. Won, P. J. Oh, K. Kim, I. Y. Hyuck, M. H. Lee, K. W. Ki, K. Park, Biochem. Biophys. Res. Commun. 2003, 300, 230.
21. W. C. Earnshaw, Curr Opin. Cell Biol. 1995, 7, 337.
22. G. Evan, T. Littlewood, Science 1998, 281, 1317.
23. S. J. Korsmeyer, Cancer Res. 1999, 59, 1693s.
24. Z. N. Oltvai, C. L. Milliman, S. J. Korsmeyer, Cell 1993, 74, 609.
25. S. Rowan, D. E. Fisher, Leukemia 1997, 11, 45.
26. N. A. Thornberry, Y. Lazebnik, Science 1998, 281, 1312.
27. D. R. Green, J. C. Reed, Science 1998, 281, 1309.
28. K. F. Izban, T. Wrone-Smith, E. D. His, B. Schnitzer, M. E. Quevedo, S. Alkan, Am. J. Pathol. 1999, 154, 1439.
29. F. L. Chan, H. L. Choi, Z. Y. Chen, P. S. F. Chan, Y. Hang, Cancer Lett. 2000, 160, 219.
30. X. L. Zheng, H. X. Sun, X. L. Liu, Y. X. Chen. B. C. Qian, Acta Pharmacol. Sin. 2004, 25, 1090.
31. J. Rajiv, L. Wi, H. Enji, Mol. Brain Res. 1993, 17, 70.
32. Y. Leng, Y. Feng, L. Cao, Z. P. Gu, Acta Pharmacol. Sin. 2001, 22, 155.
33. X. H. Zhu, Y. L. Shen, Y. K. Jing, X. Cai, P. M. Jia, Y. Huang, W. Tang, G. Y. Shi, U. P. Sun, J. Dai, Z. Y. Wang, S. J. Chen, T. D. Zhang, S. Waxman, Z. Chen, G. Q. Chen, J. Natl. Cancer Inst. 1999, 91, 772.
34. S. C. Wright, U. Schellenberger, H. Wang, D. H. Kinder. J. W. Talhouk, J. W. Larrick, J. Exp. Med. 1997, 186, 1107.